SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-20-000267
Filing Date
2020-02-27
Accepted
2020-02-27 19:51:12
Documents
1
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12789
  Complete submission text file 0001012975-20-000267.txt   16217
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address
GOODMAN COREY S (Reporting) CIK: 0001278411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20664981

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address
Adelman Robert J (Reporting) CIK: 0001329161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20664980

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Reporting) CIK: 0001634632 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20664977

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic GP II, Ltd. (Reporting) CIK: 0001729408 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20664979

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic GP II, L.P. (Reporting) CIK: 0001729409 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20664978

Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations